lowest dose of semaglutide for weight loss Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). educational comparison only—these are Ozempic® Pen Dosing | Ozempic®

Theres also data showing that people with diabetes on GLP-1s have lower rates of substance use disorders than those not taking them

The STEP-1 trial demonstrated that in patients who were overweight or obese, semaglutide 2.4 mg vs

Important: IV therapy is provider-directed and not appropriate for everyone

Symptom tracking This is where lupus makes tirzepatide monitoring uniquely challenging

No cases of pancreatitis or thyroid malignancy were reported during the trial period, though these remain areas of ongoing surveillance given their association with this drug class

USP standards for sterile water and benzyl alcohol provide reference specifications referenced by BAC Water Depot's manufacturing